Alpha Healthcare III (ALPA) Signs LOI with Post-Close Acquisition for Carmell Deal
by Nicholas Alan Clayton on 2023-06-27 at 7:42am

Alpha Healthcare III (NASDAQ:ALPA) announced this morning that it has signed a non-binding LOI for its combination Carmell Therapeutics to acquire an unnamed commercial-stage biotech firm for about $65 million.

The consideration would come in the form of $8 million in cash and $57 million in combined Carmell stock at close plus $75 million in potential milestone payments paid out along the same split (12% cash and 88% shares). This target company’s shares would be locked for 12 months following close.

The $140 million total potential value of this acquisition comes close to doubling the scale of the initial combination with Carmell, which was struck at $188 million enterprise value. Pittsburgh-based Carmell is developing a treatment platform to accelerate healing in bone fractures and soft tissue wounds.

It could also provide Carmell with some cash flow nearer at hand post-close as the target generated about $5 million in EBITDA from $50 million in revenue during the 12 months ending March 31, 2023.

The target also has a sales contract in place with a purchasing organization with coverage in about 1,500 US hospitals. Carmell’s therapies on the other hand remain at the clinical stage with its most advanced candidates undergoing Phase II trials.

This acquisition agreement remains non-binding, however, and may not come to fruition. In the meantime, it may serve as an amuse-bouche for Alpha Healthcare III investors as they head into a completion vote for the Carmell deal on July 11.

 

 

Recent Posts
by Kristi Marvin on 2024-06-08 at 9:52am

Terms Tracker for the Week Ending June 7, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. As expected, June is looking like a much more active month for SPACs, particularly on the new issuance front. Four more new SPACs got filed...

by Nicholas Alan Clayton on 2024-06-07 at 3:19pm

GigCapital7 Corp. (NASDAQ:GIGGU) has brought a unique twist to the return of serial SPAC sponsors and flair of DIY to its filing for a $250 million IPO. Like many SPACs filed over the past month, the vehicle has already seen “non-managing investors” call dibs on $247.5 million of the offering’s units via expressions of interest,...

by Nicholas Alan Clayton on 2024-06-07 at 12:11pm

Electric vertical takeoff and landing (eVTOL) developers emerged as a second wave EV deal during the SPAC boom, but as they near clearance to fly, their first markets look significantly different than they did at announcement. Four SPACs completed combinations with eVTOL developers during a four-month stretch from August to December 2021, with two more...

by Nicholas Alan Clayton on 2024-06-07 at 10:12am

Chenghe Acquisition II Co. (NYSE:CHEB.U) announced the pricing of its $75 million IPO and its units are expected to begin trading on the NYSE American under the symbol “CHEB.U”, Friday, June 7, 2024. The new SPAC intends to focus its target search on Asian targets in the consumer and e-commerce sectors with the capability of...

by Nicholas Alan Clayton on 2024-06-07 at 8:27am

At the SPAC of Dawn WinVest (NASDAQ:WINV) broke a month-long silence of new SPAC deal announcements in May, but has kept investors waiting for more details on its combination with Italian ad-targeting marketplace Xtribe until it dropped a new presentation yesterday. The deck makes clear that although Xtribe’s operations have been largely limited to its...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved